|
Deuterium depleted water effects on survival of lung cancer patients and expression of Kras, Bcl2, and Myc genes in mouse lung. |
100.00% |
|
IS THERE A COVID VACCINE / CANCER CONNECTION? |
100.00% |
|
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with unresectable metastatic colorectal carcinoma. |
100.00% |
|
Psychodynamic pain management for cancer patients |
100.00% |
|
A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced non-s |
100.00% |
|
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with metastatic bladder cancer. |
100.00% |
|
CLINICAL EXPERIENCE OF CANCER IMMUNOTHERAPY INTEGRATED WITH OLEIC ACID COMPLEXED WITH DE-GLYCOSYLATED VITAMIN D BINDING PROTEIN |
100.00% |
|
A prospective observational clinical study involving an alternative cancer treatment, psorinum therapy, in treating stomach, gal |
100.00% |
|
Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma. |
100.00% |
|
63 year old woman with stage III malignant melanoma |
100.00% |
|
Stoppa Massmordet! |
100.00% |
|
Holistisk Cancer Behandling och Cancer Psykoterapi Inspirerad av Dr. Fred B. Levenson |
100.00% |
|
Active specific immunotherapy with supportive measures in the treatment of palliatively nephrectomized, renal adenocarcinoma pat |
100.00% |
|
Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. |
100.00% |
|
Reversal of Signs and Symptoms of a B-Cell Lymphoma in a Patient Using Only Low-Dose Naltrexone |
100.00% |
|
Prof. Meyl detected DNA-Wave and Scalar Wave Biology |
100.00% |
|
Psychodynamic psychotherapy, therapeutic touch and cancer. A review of the method of intervention and studv of 75 cases |
100.00% |
|
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. |
100.00% |
|
Deuterium Depletion Inhibits Cell Proliferation, RNA and Nuclear Membrane Turnover to Enhance Survival in Pancreatic Cancer |
100.00% |
|
Sen. Ron Johnson Sends Letter to Sec. of Defense Demanding Information on Shockingly High COVID-19 Vaccine Injury Among Military Personnel |
100.00% |
|
Prof. Meyl upptäckte DNA-vågor och Skalär Våg Biologi |
100.00% |
|
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with unresectable m |
100.00% |
|
Oleic Acid, deglycosylated vitamin D-binding protein, nitric oxide: a molecular triad made lethal to cancer. |
100.00% |
|
3-Bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective "small molecule" anti-cancer agent taken from labside to bedside: introduction to a special issue. |
100.00% |
|
Psorinum therapy in treating stomach, gall bladder, pancreatic, and liver cancers: a prospective clinical study. |
100.00% |
|
75 year old man, Prostate Cancer with bone and liver metastasis |
100.00% |
|
Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus. |
100.00% |
|
Independent Medicine - How to improve health by applying cheap, safe, and effective healing methods. |
100.00% |
|
Enzymatically Extracted Apple Pectin Possesses Antioxidant and Antitumor Activity |
100.00% |
|
Low Dose naltrexone |
100.00% |
|
Why is not Ukrain approved yet in Austria/EU? |
98.57% |
|
Bio-Immune therapy according to Professor Thomas Tallberg, a cure for Melanoma? |
97.50% |
|
DCA |
97.50% |
|
Low-dose naltrexone for disease prevention and quality of life. |
95.00% |
|
Phase II study of docetaxel-prednisone (DP) in combination with metronomic cyclophosphamide (CTX) and celecoxib (C) ...... |
95.00% |
|
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up. |
95.00% |
|
Ukrain (NSC-631570) in the treatment of pancreas cancer. |
95.00% |
|
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. |
95.00% |
|
Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract. |
95.00% |
|
Psorinum, the anti cancer miracle from India. |
91.47% |
|
The PEP-C regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy. |
90.00% |
|
Randomized Trials of Selenium, Vitamin E, or Vitamin C for Prostate Cancer Prevention |
90.00% |
|
A randomized trial of personalized peptide vaccine (PPV) plus low-dose estramustine (EMP) versus full-dose EMP in patients ..... |
90.00% |
|
Immunomodulatory effects of opioids. |
90.00% |
|
RECURRENCE OF BRAIN TUMORS MAY BE PREVENTED WITH RUTA AND CALCAREA PHOSPHORICA |
90.00% |
|
Current perspectives on the medicinal potentials of Vernonia amygdalina Del. |
90.00% |
|
61 year old woman, Breast cancer with lymph, and lung metastasis |
90.00% |
|
A homeopathic approach to treat patients with advanced gallbladder, periampullary, and liver carcinomas: a report of 3 cases. |
90.00% |
|
Mycoplasma infections and different human carcinomas. |
90.00% |
|
Electromagnetic energy as a bridge between atomic and cellular levels in the genetics approach to cancer treatment. |
90.00% |
|
Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs. |
90.00% |
|
Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prosta |
90.00% |
|
WHO’S AFRAID OF A CURE FOR CANCER? - The struggle for an alternative cancer drug |
90.00% |
|
Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation. |
90.00% |
|
Albumin Concentration Controls Cancer |
90.00% |
|
Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure |
90.00% |
|
Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins. |
90.00% |
|
71 year old woman, Pancraetic cancer with liver and lung metastasis. |
90.00% |
|
Efficacy of homeopathic therapy in cancer treatment |
90.00% |
|
Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. |
90.00% |
|
Opioid growth factor and the treatment of human pancreatic cancer: a review. |
90.00% |
|
Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. |
90.00% |
|
Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. Sub-category: Cell-Based Therapy |
90.00% |
|
Hyperthermia adds to chemotherapy. |
90.00% |
|
Metabolic modulation of glioblastoma with dichloroacetate. |
90.00% |
|
Clinical Investigations on Ukrain |
90.00% |
|
Open Source Cancer Resaearch - A video |
90.00% |
|
Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis. |
90.00% |
|
Role of infectious agents in the emergence of malignant tumors |
90.00% |
|
The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alp |
90.00% |
|
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. |
90.00% |
|
Dendritic cell-based vaccination in combination with gemcitabine/S-1 in patients with advanced pancreatic cancer. Sub-category: |
90.00% |
|
Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic soli |
90.00% |
|
Pre-Clinical Investigations on Ukrain |
90.00% |
|
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic ca |
90.00% |
|
Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis. |
90.00% |
|
Adaptive therapy. |
90.00% |
|
71 year old woman. Breast cancer with bone metastasis |
90.00% |
|
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor acti |
90.00% |
|
Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer. |
90.00% |
|
Therapeutic vaccination with an autologous TriMix-Dendritic cell vaccine combined with sequential interferon alfa-2b in ........ |
90.00% |
|
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. |
90.00% |
|
20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and |
90.00% |
|
Treatment of advanced pancreatic cancer with opioid growth factor: phase I. |
90.00% |
|
Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's .... |
90.00% |
|
In-vitro toxicity of Ukrain against human Ewing tumor cell lines. |
90.00% |
|
A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced esoph |
90.00% |
|
Debate in Lancet about setting up a phase II trial on Ukrain in England |
90.00% |
|
Vitamin D for cancer prevention: global perspective. |
90.00% |
|
NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell |
90.00% |
|
Case Report: A Breast Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Hormone Therapy |
90.00% |
|
Artesunate in the treatment of metastatic uveal melanoma--first experiences. |
90.00% |
|
Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador). |
90.00% |
|
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy. |
90.00% |
|
A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. |
90.00% |
|
Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a |
90.00% |
|
Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. |
90.00% |
|
Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potent |
90.00% |
|
Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancer. |
90.00% |
|
Ukrain - a new cancer cure? A systematic review of randomised clinical trials. |
90.00% |
